Introduction to Semaglutide for Weight Loss
Semaglutide (brand names Ozempic, Wegovy) is an injectable prescription medication originally approved for treating type 2 diabetes. More recently, a higher dose of semaglutide was approved by the FDA specifically for chronic weight management in obese adults.
Semaglutide works by mimicking the hormone GLP-1, which helps regulate blood sugar levels and appetite. By acting like GLP-1, semaglutide slows digestion and suppresses appetite, leading to decreased food intake and significant weight loss.
In clinical trials, people taking semaglutide lost an average of 12-15% of their body weight over 68 weeks when combined with diet and exercise. This amount of weight loss can have dramatic impacts on obesity-related health conditions like diabetes, high blood pressure, and high cholesterol.